Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINISTONE-2: Baloxavir Marboxil vs Oseltamivir in Pediatric Influenza
NCT03629184Phase 3Completed
- Sponsor
- Roche
- Start
- Nov 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of baloxavir marboxil in influenza, sponsored by Roche. Started Nov 2018; status: completed.
02
Drugs
baloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03629184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03629184.